# Dydrogesterone

## Duphaston 10mg

| 藥物代碼           | ODUP1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Treatment of progesterone deficiencies; counteract unopposed estrogen in hormone replacement therapy.Luteal support as part of assisted reproductive technology.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 副作用             | Migraines/headache, jaundice, asthenia (weakness) or malaise, abdominal pain, rash, pruritus, urticaria, metrorrhagia, breast pain/tenderness.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 禁忌               | Hypersensitivity, progestogen dependent neoplasm to prevent endometrial hyperplasia, abnormal vag bleeding.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 藥物保存方式       | 室溫                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 用法用量           | Infertility 10 mg bid from day 14-25 of the cycle. Threatened abortion: 40 mg at once then 10 mg 8 hrly until symptoms remit. Habitual abortion: 10 mg bid until the 20th wk of pregnancy. Primary dysmenorrhea: 10 mg bid from day 5-25 of the cycle. Endometriosis: 10 mg bid-tid from day 5-25 of the cycle or continuously. Premenstrual syndrome: 10 mg bid from day 11-25 of the cycle. Secondary amenorrhea: An oestrogen once daily from day 1-25 of the cycle and then with 10 mg dydrogesterone bid from day 11-25 of the cycle. Postmenopausal complaints: In combination w/ cyclical oestrogen therapy: 10-20 mg daily during 14 consecutive days per cycle of 28 days. In combination w/ continuous oestrogen therapy: 10-20 mg during the last 12-14 days of each cycle. Luteal support as part of assisted reproductive technology:10 mg tid starting at the day of oocyte retrieval & continuing for 10 weeks if pregnancy is confirmed. |
| 肝功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 懷孕用藥危分級     | 尚未確立                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 孕期用藥建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 附帶說明           | Use of vaginal progesterone may be considered to decrease the risk of recurrent spontaneous preterm birth in women with a singleton pregnancy and prior spontaneous preterm singleton birth (therapy may begin at 16 to 24 weeks, regardless of cervical length). It may also be used to prevent spontaneous preterm birth in women with a singleton pregnancy  who have a cervix <20 mm before or at 24 weeks' gestation.  Use is not recommended as an intervention for women with multiple gestations (ACOG 2012) .(UpToDate)2021/0125                                                                                                                                                                                                                                                                                                                                                                                                                |
| 哺乳期用藥建議     | Unknown 尚未建立                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 附帶說明           | Breastfeeding recommendations vary by manufacturer; the decision to breastfeed during therapy should consider the risk of infant exposure, the benefits of breastfeeding to the infant,  and the benefits of treatment to the mother. (UpToDate)2021/0125                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 注射劑給藥建議途徑 | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 注意事項           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |

